https://www.marketscreener.com/quote/stock/ACTELION-9364986/news/Actelion-is-granted-marketing-authorization-for-Uptravi-selexipag-in-pulmonary-arterial-hyperten-22369942/?utm_source=telegram&utm_medium=social&utm_campaign=share